ABSTRACT
Introduction Previous studies have established that depressive syndromes can be detected using machine learning methods, with multimodal data being essential. Multimodal data facilitates the extraction of characteristics such as gaze tracking, a reliable depression indicator. Our study employs high-quality video and other multimodal data from patients diagnosed with depression. Our study uses a multimodal data collection system (MDC) to understand the complex indicators of depression.
Objective This paper outlines our protocol for deploying a multimodal data collection system within an In-Person Clinical Assessment environment. The system gathers high-definition videos, real-time vital signs, and voice recordings for future extraction of critical information such as eye gaze patterns. We aim to scale our model to provide portable depression risk analyses, facilitating timely intervention and encouraging patients to seek professional assistance.
Methods and Analysis We have conducted sessions with 70 participants diagnosed with depression. Each participant undergoes DSM-5 interviews and engages with our multimodal data collection system. Participants respond to five on-screen scales while being recorded. To our knowledge, no other protocol has combined multimodal data collection and various stimuli in depression data collection.
Ethics and Dissemination Ethical approval was provided by the National Health Commission of the PRC, Hefei Fourth People’s Hospital Ethics Committee (HSY-IRB-YJ-YYYX-JYF001). Results will be published in a peer-reviewed journal and presented at academic conferences.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by the National Natural Science Foundation of China under Grant 62176084, and Grant 62176083, and in part by the National Key Research and Development Program of China under Grant 2023YFC3604704
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was provided by the National Health Commission of the PRC, Hefei Fourth People's Hospital Ethics Committee (HSY-IRB-YJ-YYYX-JYF001).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Non patient-identifiable data produced in the present study are available upon reasonable request to the authors
